The availability of limited amounts of patient TEM was partially overcome by taking advantage of our recently developed model system of TEM differentiated in vitro by exposing CD34+ cord blood hematopoietic progenitors to breast cancer cell conditioned culture medium [38,40]. The gene discussed is CD34; the disease is breast cancer.